Compile Data Set for Download or QSAR

Found 258 hits Enz. Inhib. hit(s) with all data for entry = 6043   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105283 (US8575203, I-50) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn([C@@H](CO)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C32H32F2N6O3/c1-2-39-15-11-23(12-16-39)37-30-19-36-27-10-7-21(17-28(27)38-30)5-3-13-35-31(42)24-6-4-14-40(32(24)43)29(20-41)22-8-9-25(33)26(34)18-22/h4,6-10,14,17-19,23,29,41H,2,11-13,15-16,20H2,1H3,(H,35,42)(H,37,38)/t29-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105303 (US8575203, I-70) Show SMILES CN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C30H28F2N6O2/c1-37-11-8-23(9-12-37)36-24-15-22-13-20(5-7-28(22)35-16-24)3-2-10-34-29(39)25-17-33-19-38(30(25)40)18-21-4-6-26(31)27(32)14-21/h4-7,13-17,19,23,36H,8-12,18H2,1H3,(H,34,39)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105308 (US8575203, I-75) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cccn([C@@H](C)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C33H33F2N5O2/c1-3-39-16-12-26(13-17-39)38-27-19-25-18-23(8-11-31(25)37-21-27)6-4-14-36-32(41)28-7-5-15-40(33(28)42)22(2)24-9-10-29(34)30(35)20-24/h5,7-11,15,18-22,26,38H,3,12-14,16-17H2,1-2H3,(H,36,41)/t22-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105263 (US8575203, I-30) Show SMILES C[C@H](c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(NC4CCN(C)CC4)nc3c2)c1=O |r| Show InChI InChI=1S/C31H30F2N6O2/c1-20(22-8-9-25(32)26(33)18-22)39-14-4-6-24(31(39)41)30(40)34-13-3-5-21-7-10-27-28(17-21)37-29(19-35-27)36-23-11-15-38(2)16-12-23/h4,6-10,14,17-20,23H,11-13,15-16H2,1-2H3,(H,34,40)(H,36,37)/t20-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105273 (US8575203, I-40) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4ncc(N[C@H]5CC[C@@H](CC5)N5CCOCC5)nc4c3)c2=O)cc1F |r,wU:25.24,wD:28.31,(8.67,-.39,;7.34,.38,;7.34,1.92,;6,2.69,;4.67,1.92,;3.33,2.69,;3.33,4.23,;4.67,5,;4.67,6.54,;3.33,7.31,;2,6.54,;.67,7.31,;.67,8.85,;-.67,6.54,;-.67,5,;-2,4.23,;-3.33,3.46,;-4.67,2.69,;-6,3.46,;-7.34,2.69,;-7.34,1.15,;-8.67,.38,;-8.67,-1.16,;-7.34,-1.93,;-7.34,-3.47,;-6,-4.24,;-4.67,-3.47,;-3.33,-4.24,;-3.33,-5.78,;-4.67,-6.55,;-6,-5.78,;-2,-6.55,;-2,-8.09,;-.67,-8.85,;.67,-8.09,;.67,-6.55,;-.67,-5.78,;-6,-1.16,;-6,.38,;-4.67,1.15,;2,5,;.67,4.23,;4.67,.38,;6,-.39,;6,-1.93,)| Show InChI InChI=1S/C33H33F2N7O3/c34-27-9-3-23(16-28(27)35)20-42-21-36-18-26(33(42)44)32(43)37-11-1-2-22-4-10-29-30(17-22)40-31(19-38-29)39-24-5-7-25(8-6-24)41-12-14-45-15-13-41/h3-4,9-10,16-19,21,24-25H,5-8,11-15,20H2,(H,37,43)(H,39,40)/t24-,25-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105284 (US8575203, I-51) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn([C@@H](C)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C31H31F2N7O2/c1-3-39-13-10-23(11-14-39)37-29-18-36-27-9-6-21(15-28(27)38-29)5-4-12-35-30(41)24-17-34-19-40(31(24)42)20(2)22-7-8-25(32)26(33)16-22/h6-9,15-20,23H,3,10-14H2,1-2H3,(H,35,41)(H,37,38)/t20-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105294 (US8575203, I-61) Show SMILES OC[C@H](c1cccc(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(N[C@H]4CC[C@@H](CC4)N4CCN(CC5CC5)CC4)nc3c2)c1=O |r,wU:2.10,29.29,wD:32.36,(2,1.54,;3.33,.77,;4.67,1.54,;6,.77,;7.34,1.54,;8.67,.77,;8.67,-.77,;7.34,-1.54,;7.34,-3.08,;6,-.77,;4.67,3.08,;6,3.85,;6,5.39,;4.67,6.16,;3.33,5.39,;2,6.16,;2,7.7,;.67,5.39,;-.67,6.16,;-2,5.39,;-3.33,4.62,;-4.67,3.85,;-6,4.62,;-7.34,3.85,;-7.34,2.31,;-8.67,1.54,;-8.67,,;-7.34,-.77,;-7.34,-2.31,;-6,-3.08,;-4.67,-2.31,;-3.33,-3.08,;-3.33,-4.62,;-4.67,-5.39,;-6,-4.62,;-2,-5.39,;-2,-6.93,;-.67,-7.7,;.67,-6.93,;2,-7.7,;3.33,-6.93,;4.87,-6.93,;4.1,-5.6,;.67,-5.39,;-.67,-4.62,;-6,,;-6,1.54,;-4.67,2.31,;3.33,3.85,;2,3.08,)| Show InChI InChI=1S/C39H44FN7O3/c40-30-6-1-5-29(23-30)36(26-48)47-17-3-7-33(39(47)50)38(49)41-16-2-4-27-10-15-34-35(22-27)44-37(24-42-34)43-31-11-13-32(14-12-31)46-20-18-45(19-21-46)25-28-8-9-28/h1,3,5-7,10,15,17,22-24,28,31-32,36,48H,8-9,11-14,16,18-21,25-26H2,(H,41,49)(H,43,44)/t31-,32-,36-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105295 (US8575203, I-62) Show SMILES Fc1ccc(Cn2nccc(C(=O)NCC#Cc3ccc4ncc(N[C@H]5CC[C@@H](CC5)N5CCN(CC6CC6)CC5)nc4c3)c2=O)cc1F |r,wU:25.24,wD:28.31,(9.34,-1.54,;8,-.77,;8,.77,;6.67,1.54,;5.33,.77,;4,1.54,;4,3.08,;5.33,3.85,;5.33,5.39,;4,6.16,;2.67,5.39,;1.33,6.16,;1.33,7.7,;,5.39,;-1.33,6.16,;-2.67,5.39,;-4,4.62,;-5.33,3.85,;-6.67,4.62,;-8,3.85,;-8,2.31,;-9.34,1.54,;-9.34,,;-8,-.77,;-8,-2.31,;-6.67,-3.08,;-5.33,-2.31,;-4,-3.08,;-4,-4.62,;-5.33,-5.39,;-6.67,-4.62,;-2.67,-5.39,;-2.67,-6.93,;-1.33,-7.7,;,-6.93,;1.33,-7.7,;2.67,-6.93,;4.21,-6.93,;3.44,-5.6,;,-5.39,;-1.33,-4.62,;-6.67,,;-6.67,1.54,;-5.33,2.31,;2.67,3.85,;1.33,3.08,;5.33,-.77,;6.67,-1.54,;6.67,-3.08,)| Show InChI InChI=1S/C37H40F2N8O2/c38-31-11-5-27(20-32(31)39)24-47-37(49)30(13-15-42-47)36(48)40-14-1-2-25-6-12-33-34(21-25)44-35(22-41-33)43-28-7-9-29(10-8-28)46-18-16-45(17-19-46)23-26-3-4-26/h5-6,11-13,15,20-22,26,28-29H,3-4,7-10,14,16-19,23-24H2,(H,40,48)(H,43,44)/t28-,29-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105305 (US8575203, I-72) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C32H31F2N5O2/c1-2-38-15-11-25(12-16-38)37-26-19-24-17-22(8-10-30(24)36-20-26)5-3-13-35-31(40)27-6-4-14-39(32(27)41)21-23-7-9-28(33)29(34)18-23/h4,6-10,14,17-20,25,37H,2,11-13,15-16,21H2,1H3,(H,35,40)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105309 (US8575203, I-76) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cccn([C@H](CO)c2cccc(F)c2)c1=O |r| Show InChI InChI=1S/C33H34FN5O3/c1-2-38-16-12-27(13-17-38)37-28-20-25-18-23(10-11-30(25)36-21-28)6-4-14-35-32(41)29-9-5-15-39(33(29)42)31(22-40)24-7-3-8-26(34)19-24/h3,5,7-11,15,18-21,27,31,37,40H,2,12-14,16-17,22H2,1H3,(H,35,41)/t31-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105356 (US8575203, I-123) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4nccc(OCC5CCCNC5)c4c3)c2=O)cc1F Show InChI InChI=1S/C30H27F2N5O3/c31-25-7-5-21(14-26(25)32)17-37-19-34-16-24(30(37)39)29(38)36-11-2-3-20-6-8-27-23(13-20)28(9-12-35-27)40-18-22-4-1-10-33-15-22/h5-9,12-14,16,19,22,33H,1,4,10-11,15,17-18H2,(H,36,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105357 (US8575203, I-124) Show SMILES CC(c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OCCCN(C)C)c3c2)c1=O Show InChI InChI=1S/C31H30F2N4O3/c1-21(23-10-11-26(32)27(33)20-23)37-17-5-8-24(31(37)39)30(38)35-14-4-7-22-9-12-28-25(19-22)29(13-15-34-28)40-18-6-16-36(2)3/h5,8-13,15,17,19-21H,6,14,16,18H2,1-3H3,(H,35,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105358 (US8575203, I-125) Show SMILES CN(C)CCCOc1ccnc2ccc(cc12)C#CCNC(=O)c1cccn(C(CO)c2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C31H30F2N4O4/c1-36(2)15-5-17-41-29-12-14-34-27-11-8-21(18-24(27)29)6-3-13-35-30(39)23-7-4-16-37(31(23)40)28(20-38)22-9-10-25(32)26(33)19-22/h4,7-12,14,16,18-19,28,38H,5,13,15,17,20H2,1-2H3,(H,35,39)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105367 (US8575203, I-125.9) Show SMILES CN1CC[C@H](COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(Cc3cc(F)c(F)c(F)c3)c2=O)C1 |r| Show InChI InChI=1S/C31H27F3N4O3/c1-37-13-9-21(17-37)19-41-28-8-11-35-27-7-6-20(14-24(27)28)4-2-10-36-30(39)23-5-3-12-38(31(23)40)18-22-15-25(32)29(34)26(33)16-22/h3,5-8,11-12,14-16,21H,9-10,13,17-19H2,1H3,(H,36,39)/t21-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105375 (US8575203, I-125.17) Show SMILES CN1CCC[C@@H](COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(Cc3cc(F)c(F)c(F)c3)c2=O)C1 |r| Show InChI InChI=1S/C32H29F3N4O3/c1-38-13-3-6-22(18-38)20-42-29-10-12-36-28-9-8-21(15-25(28)29)5-2-11-37-31(40)24-7-4-14-39(32(24)41)19-23-16-26(33)30(35)27(34)17-23/h4,7-10,12,14-17,22H,3,6,11,13,18-20H2,1H3,(H,37,40)/t22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105376 (US8575203, I-125.18) Show SMILES CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@@H]4CCCN(C)C4)c3c2)c1=O |r| Show InChI InChI=1S/C33H31F3N4O3/c1-21(24-17-27(34)31(36)28(35)18-24)40-15-5-8-25(33(40)42)32(41)38-12-3-6-22-9-10-29-26(16-22)30(11-13-37-29)43-20-23-7-4-14-39(2)19-23/h5,8-11,13,15-18,21,23H,4,7,12,14,19-20H2,1-2H3,(H,38,41)/t21?,23-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105379 (US8575203, I-125.21) Show SMILES CN1CCC[C@@H](COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(C(CO)c3cc(F)c(F)c(F)c3)c2=O)C1 |r| Show InChI InChI=1S/C33H31F3N4O4/c1-39-13-3-6-22(18-39)20-44-30-10-12-37-28-9-8-21(15-25(28)30)5-2-11-38-32(42)24-7-4-14-40(33(24)43)29(19-41)23-16-26(34)31(36)27(35)17-23/h4,7-10,12,14-17,22,29,41H,3,6,11,13,18-20H2,1H3,(H,38,42)/t22-,29?/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM41966 (US8575203, I-9) Show SMILES OCCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C30H29F2N7O3/c31-24-5-3-21(14-25(24)32)18-39-19-33-16-23(30(39)42)29(41)34-9-1-2-20-4-6-26-27(15-20)37-28(17-35-26)36-22-7-10-38(11-8-22)12-13-40/h3-6,14-17,19,22,40H,7-13,18H2,(H,34,41)(H,36,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105260 (US8575203, I-27) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4ncc(NC5CCNCC5)nc4c3)c2=O)cc1F Show InChI InChI=1S/C28H25F2N7O2/c29-22-5-3-19(12-23(22)30)16-37-17-32-14-21(28(37)39)27(38)33-9-1-2-18-4-6-24-25(13-18)36-26(15-34-24)35-20-7-10-31-11-8-20/h3-6,12-15,17,20,31H,7-11,16H2,(H,33,38)(H,35,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105267 (US8575203, I-34) Show SMILES N[C@H]1CC[C@@H](CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O |r,wU:1.0,wD:4.7,(-2,-7.7,;-3.33,-6.93,;-4.67,-7.7,;-6,-6.93,;-6,-5.39,;-4.67,-4.62,;-3.33,-5.39,;-7.34,-4.62,;-7.34,-3.08,;-8.67,-2.31,;-8.67,-.77,;-7.34,,;-7.34,1.54,;-6,2.31,;-4.67,1.54,;-4.67,,;-6,-.77,;-6,-2.31,;-3.33,2.31,;-2,3.08,;-.67,3.85,;-.67,5.39,;.67,6.16,;.67,7.7,;2,5.39,;3.33,6.16,;4.67,5.39,;4.67,3.85,;3.33,3.08,;3.33,1.54,;4.67,.77,;6,1.54,;7.34,.77,;7.34,-.77,;8.67,-1.54,;6,-1.54,;6,-3.08,;4.67,-.77,;2,3.85,;.67,3.08,)| Show InChI InChI=1S/C29H27F2N7O2/c30-23-9-3-19(12-24(23)31)16-38-17-33-14-22(29(38)40)28(39)34-11-1-2-18-4-10-25-26(13-18)37-27(15-35-25)36-21-7-5-20(32)6-8-21/h3-4,9-10,12-15,17,20-21H,5-8,11,16,32H2,(H,34,39)(H,36,37)/t20-,21-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105274 (US8575203, I-41) Show SMILES CN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn([C@@H](CO)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C31H30F2N6O3/c1-38-14-10-22(11-15-38)36-29-18-35-26-9-6-20(16-27(26)37-29)4-2-12-34-30(41)23-5-3-13-39(31(23)42)28(19-40)21-7-8-24(32)25(33)17-21/h3,5-9,13,16-18,22,28,40H,10-12,14-15,19H2,1H3,(H,34,41)(H,36,37)/t28-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105275 (US8575203, I-42) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4ncc(N[C@H]5CC[C@@H](CC5)N5CCN(CC6CC6)CC5)nc4c3)c2=O)cc1F |r,wU:25.24,wD:28.31,(8.67,-.38,;7.34,.38,;7.34,1.93,;6,2.69,;4.67,1.93,;3.33,2.69,;3.33,4.23,;4.67,5,;4.67,6.54,;3.33,7.31,;2,6.54,;.67,7.31,;.67,8.85,;-.67,6.54,;-.67,5,;-2,4.23,;-3.33,3.47,;-4.67,2.69,;-6,3.47,;-7.34,2.69,;-7.34,1.15,;-8.67,.38,;-8.67,-1.15,;-7.34,-1.93,;-7.34,-3.47,;-6,-4.23,;-4.67,-3.47,;-3.33,-4.23,;-3.33,-5.78,;-4.67,-6.54,;-6,-5.78,;-2,-6.54,;-2,-8.08,;-.67,-8.85,;.67,-8.08,;2,-8.85,;3.33,-8.08,;4.87,-8.08,;4.1,-6.75,;.67,-6.54,;-.67,-5.78,;-6,-1.15,;-6,.38,;-4.67,1.15,;2,5,;.67,4.23,;4.67,.38,;6,-.38,;6,-1.93,)| Show InChI InChI=1S/C37H40F2N8O2/c38-31-11-5-27(18-32(31)39)23-47-24-40-20-30(37(47)49)36(48)41-13-1-2-25-6-12-33-34(19-25)44-35(21-42-33)43-28-7-9-29(10-8-28)46-16-14-45(15-17-46)22-26-3-4-26/h5-6,11-12,18-21,24,26,28-29H,3-4,7-10,13-17,22-23H2,(H,41,48)(H,43,44)/t28-,29-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105281 (US8575203, I-48) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn([C@@H](CO)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C33H34F2N6O4/c1-45-17-16-40-14-10-24(11-15-40)38-31-20-37-28-9-6-22(18-29(28)39-31)4-2-12-36-32(43)25-5-3-13-41(33(25)44)30(21-42)23-7-8-26(34)27(35)19-23/h3,5-9,13,18-20,24,30,42H,10-12,14-17,21H2,1H3,(H,36,43)(H,38,39)/t30-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105289 (US8575203, I-56) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4ncc(NC5CCN(CC5)C5COC5)nc4c3)c2=O)cc1F Show InChI InChI=1S/C31H29F2N7O3/c32-25-5-3-21(12-26(25)33)16-40-19-34-14-24(31(40)42)30(41)35-9-1-2-20-4-6-27-28(13-20)38-29(15-36-27)37-22-7-10-39(11-8-22)23-17-43-18-23/h3-6,12-15,19,22-23H,7-11,16-18H2,(H,35,41)(H,37,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105355 (US8575203, I-122) Show SMILES Fc1ccc(Cn2cncc(C(=O)NCC#Cc3ccc4nccc(OCC5CCNC5)c4c3)c2=O)cc1F Show InChI InChI=1S/C29H25F2N5O3/c30-24-5-3-20(13-25(24)31)16-36-18-33-15-23(29(36)38)28(37)35-9-1-2-19-4-6-26-22(12-19)27(8-11-34-26)39-17-21-7-10-32-14-21/h3-6,8,11-13,15,18,21,32H,7,9-10,14,16-17H2,(H,35,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105359 (US8575203, I-125.1) Show SMILES CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@@H]4CCN(C)C4)c3c2)c1=O |r| Show InChI InChI=1S/C32H29F3N4O3/c1-20(23-16-26(33)30(35)27(34)17-23)39-13-4-6-24(32(39)41)31(40)37-11-3-5-21-7-8-28-25(15-21)29(9-12-36-28)42-19-22-10-14-38(2)18-22/h4,6-9,12-13,15-17,20,22H,10-11,14,18-19H2,1-2H3,(H,37,40)/t20?,22-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105368 (US8575203, I-125.10) Show SMILES CC(c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@H]4CCN(C)C4)c3c2)c1=O |r| Show InChI InChI=1S/C32H30F2N4O3/c1-21(24-8-9-27(33)28(34)18-24)38-15-4-6-25(32(38)40)31(39)36-13-3-5-22-7-10-29-26(17-22)30(11-14-35-29)41-20-23-12-16-37(2)19-23/h4,6-11,14-15,17-18,21,23H,12-13,16,19-20H2,1-2H3,(H,36,39)/t21?,23-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105377 (US8575203, I-125.19) Show SMILES Fc1cc(Cn2cccc(C(=O)NCC#Cc3ccc4nccc(OC[C@@H]5CCCN(CCN6CCOCC6)C5)c4c3)c2=O)cc(F)c1F |r| Show InChI InChI=1S/C37H38F3N5O4/c38-31-21-28(22-32(39)35(31)40)24-45-13-3-6-29(37(45)47)36(46)42-10-1-4-26-7-8-33-30(20-26)34(9-11-41-33)49-25-27-5-2-12-44(23-27)15-14-43-16-18-48-19-17-43/h3,6-9,11,13,20-22,27H,2,5,10,12,14-19,23-25H2,(H,42,46)/t27-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105380 (US8575203, I-125.22) Show SMILES CC(C)N1CCC[C@@H](COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(Cc3ccc(F)c(F)c3)c2=O)C1 |r| Show InChI InChI=1S/C34H34F2N4O3/c1-23(2)39-16-4-7-26(21-39)22-43-32-13-15-37-31-12-10-24(18-28(31)32)6-3-14-38-33(41)27-8-5-17-40(34(27)42)20-25-9-11-29(35)30(36)19-25/h5,8-13,15,17-19,23,26H,4,7,14,16,20-22H2,1-2H3,(H,38,41)/t26-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105252 (US8575203, 297 | US8575203, I-19/I-20) Show SMILES CN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C29H27F2N7O2/c1-37-11-8-21(9-12-37)35-27-16-34-25-7-5-19(14-26(25)36-27)3-2-10-33-28(39)22-15-32-18-38(29(22)40)17-20-4-6-23(30)24(31)13-20/h4-7,13-16,18,21H,8-12,17H2,1H3,(H,33,39)(H,35,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105252 (US8575203, 297 | US8575203, I-19/I-20) Show SMILES CN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C29H27F2N7O2/c1-37-11-8-21(9-12-37)35-27-16-34-25-7-5-19(14-26(25)36-27)3-2-10-33-28(39)22-15-32-18-38(29(22)40)17-20-4-6-23(30)24(31)13-20/h4-7,13-16,18,21H,8-12,17H2,1H3,(H,33,39)(H,35,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105280 (US8575203, I-47) Show SMILES CCN1CC[C@H](Nc2cnc3ccc(cc3n2)C#CCNC(=O)c2cncn(Cc3ccc(F)c(F)c3)c2=O)[C@H](F)C1 |r| Show InChI InChI=1S/C30H28F3N7O2/c1-2-39-11-9-25(24(33)17-39)37-28-15-36-26-8-6-19(13-27(26)38-28)4-3-10-35-29(41)21-14-34-18-40(30(21)42)16-20-5-7-22(31)23(32)12-20/h5-8,12-15,18,24-25H,2,9-11,16-17H2,1H3,(H,35,41)(H,37,38)/t24-,25+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105285 (US8575203, I-52) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn([C@@H](C)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C33H34F2N6O3/c1-22(24-8-9-27(34)28(35)20-24)41-14-4-6-26(33(41)43)32(42)36-13-3-5-23-7-10-29-30(19-23)39-31(21-37-29)38-25-11-15-40(16-12-25)17-18-44-2/h4,6-10,14,19-22,25H,11-13,15-18H2,1-2H3,(H,36,42)(H,38,39)/t22-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105288 (US8575203, I-55) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn([C@H](CO)c2cccc(F)c2)c1=O |r| Show InChI InChI=1S/C33H35FN6O4/c1-44-18-17-39-15-11-26(12-16-39)37-31-21-36-28-10-9-23(19-29(28)38-31)5-3-13-35-32(42)27-8-4-14-40(33(27)43)30(22-41)24-6-2-7-25(34)20-24/h2,4,6-10,14,19-21,26,30,41H,11-13,15-18,22H2,1H3,(H,35,42)(H,37,38)/t30-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105296 (US8575203, I-63) Show SMILES OC[C@H](c1cccc(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(NC4CCN(CC4)C4COC4)nc3c2)c1=O |r| Show InChI InChI=1S/C33H33FN6O4/c34-24-6-1-5-23(17-24)30(19-41)40-13-3-7-27(33(40)43)32(42)35-12-2-4-22-8-9-28-29(16-22)38-31(18-36-28)37-25-10-14-39(15-11-25)26-20-44-21-26/h1,3,5-9,13,16-18,25-26,30,41H,10-12,14-15,19-21H2,(H,35,42)(H,37,38)/t30-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105304 (US8575203, I-71) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C31H30F2N6O2/c1-2-38-12-9-24(10-13-38)37-25-16-23-14-21(6-8-29(23)36-17-25)4-3-11-35-30(40)26-18-34-20-39(31(26)41)19-22-5-7-27(32)28(33)15-22/h5-8,14-18,20,24,37H,2,9-13,19H2,1H3,(H,35,40)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105306 (US8575203, I-73) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C32H32F2N6O3/c1-43-14-13-39-11-8-25(9-12-39)38-26-17-24-15-22(5-7-30(24)37-18-26)3-2-10-36-31(41)27-19-35-21-40(32(27)42)20-23-4-6-28(33)29(34)16-23/h4-7,15-19,21,25,38H,8-14,20H2,1H3,(H,36,41)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105310 (US8575203, I-77) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2c1)C#CCNC(=O)c1cccn([C@@H](CO)c2ccc(F)c(F)c2)c1=O |r| Show InChI InChI=1S/C34H35F2N5O4/c1-45-17-16-40-14-10-26(11-15-40)39-27-19-25-18-23(6-9-31(25)38-21-27)4-2-12-37-33(43)28-5-3-13-41(34(28)44)32(22-42)24-7-8-29(35)30(36)20-24/h3,5-9,13,18-21,26,32,39,42H,10-12,14-17,22H2,1H3,(H,37,43)/t32-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105369 (US8575203, I-125.11) Show SMILES CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@H]4CCN(C)C4)c3c2)c1=O |r| Show InChI InChI=1S/C32H29F3N4O3/c1-20(23-16-26(33)30(35)27(34)17-23)39-13-4-6-24(32(39)41)31(40)37-11-3-5-21-7-8-28-25(15-21)29(9-12-36-28)42-19-22-10-14-38(2)18-22/h4,6-9,12-13,15-17,20,22H,10-11,14,18-19H2,1-2H3,(H,37,40)/t20?,22-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105381 (US8575203, I-125.23) Show SMILES Fc1ccc(Cn2cccc(C(=O)NCC#Cc3ccc4nccc(OC[C@@H]5CCCNC5)c4c3)c2=O)cc1F |r| Show InChI InChI=1S/C31H28F2N4O3/c32-26-9-7-22(17-27(26)33)19-37-15-3-6-24(31(37)39)30(38)36-13-2-4-21-8-10-28-25(16-21)29(11-14-35-28)40-20-23-5-1-12-34-18-23/h3,6-11,14-17,23,34H,1,5,12-13,18-20H2,(H,36,38)/t23-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105264 (US8575203, I-31) Show SMILES CN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C30H28F2N6O2/c1-37-14-10-22(11-15-37)35-28-18-34-26-9-7-20(17-27(26)36-28)4-2-12-33-29(39)23-5-3-13-38(30(23)40)19-21-6-8-24(31)25(32)16-21/h3,5-9,13,16-18,22H,10-12,14-15,19H2,1H3,(H,33,39)(H,35,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105270 (US8575203, I-37) Show SMILES COCCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C31H31F2N7O3/c1-43-14-13-39-11-8-23(9-12-39)37-29-18-36-27-7-5-21(16-28(27)38-29)3-2-10-35-30(41)24-17-34-20-40(31(24)42)19-22-4-6-25(32)26(33)15-22/h4-7,15-18,20,23H,8-14,19H2,1H3,(H,35,41)(H,37,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105276 (US8575203, I-43) Show SMILES CN(C)[C@H]1CC[C@@H](CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O |r,wU:3.2,wD:6.9,(-2,-8.47,;-2,-6.93,;-.67,-6.16,;-3.33,-6.16,;-4.67,-6.93,;-6,-6.16,;-6,-4.62,;-4.67,-3.85,;-3.33,-4.62,;-7.34,-3.85,;-7.34,-2.31,;-8.67,-1.54,;-8.67,,;-7.34,.77,;-7.34,2.31,;-6,3.08,;-4.67,2.31,;-4.67,.77,;-6,,;-6,-1.54,;-3.33,3.08,;-2,3.85,;-.67,4.62,;-.67,6.16,;.67,6.93,;.67,8.47,;2,6.16,;3.33,6.93,;4.67,6.16,;4.67,4.62,;3.33,3.85,;3.33,2.31,;4.67,1.54,;6,2.31,;7.34,1.54,;7.34,,;8.67,-.77,;6,-.77,;6,-2.31,;4.67,,;2,4.62,;.67,3.85,)| Show InChI InChI=1S/C31H31F2N7O2/c1-39(2)23-9-7-22(8-10-23)37-29-17-36-27-12-6-20(15-28(27)38-29)4-3-13-35-30(41)24-16-34-19-40(31(24)42)18-21-5-11-25(32)26(33)14-21/h5-6,11-12,14-17,19,22-23H,7-10,13,18H2,1-2H3,(H,35,41)(H,37,38)/t22-,23-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105292 (US8575203, I-59) Show SMILES OC[C@H](c1ccccc1)n1cccc(C(=O)NCC#Cc2ccc3ncc(N[C@H]4CC[C@@H](CC4)N4CCOCC4)nc3c2)c1=O |r,wU:2.9,28.28,wD:31.35,(2,1.54,;3.33,.77,;4.67,1.54,;6,.77,;6,-.77,;7.34,-1.54,;8.67,-.77,;8.67,.77,;7.34,1.54,;4.67,3.08,;6,3.85,;6,5.39,;4.67,6.16,;3.33,5.39,;2,6.16,;2,7.7,;.67,5.39,;-.67,6.16,;-2,5.39,;-3.33,4.62,;-4.67,3.85,;-6,4.62,;-7.34,3.85,;-7.34,2.31,;-8.67,1.54,;-8.67,,;-7.34,-.77,;-7.34,-2.31,;-6,-3.08,;-4.67,-2.31,;-3.33,-3.08,;-3.33,-4.62,;-4.67,-5.39,;-6,-4.62,;-2,-5.39,;-2,-6.93,;-.67,-7.7,;.67,-6.93,;.67,-5.39,;-.67,-4.62,;-6,,;-6,1.54,;-4.67,2.31,;3.33,3.85,;2,3.08,)| Show InChI InChI=1S/C35H38N6O4/c42-24-32(26-7-2-1-3-8-26)41-17-5-9-29(35(41)44)34(43)36-16-4-6-25-10-15-30-31(22-25)39-33(23-37-30)38-27-11-13-28(14-12-27)40-18-20-45-21-19-40/h1-3,5,7-10,15,17,22-23,27-28,32,42H,11-14,16,18-21,24H2,(H,36,43)(H,38,39)/t27-,28-,32-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105297 (US8575203, I-64) Show SMILES OC[C@H](c1cccc(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(N[C@H]4CC[C@@H](CC4)N4CCOCC4)nc3c2)c1=O |r,wU:2.10,29.29,wD:32.36,(2,1.54,;3.33,.77,;4.67,1.54,;6,.77,;7.34,1.54,;8.67,.77,;8.67,-.77,;7.34,-1.54,;7.34,-3.08,;6,-.77,;4.67,3.08,;6,3.85,;6,5.39,;4.67,6.16,;3.33,5.39,;2,6.16,;2,7.7,;.67,5.39,;-.67,6.16,;-2,5.39,;-3.33,4.62,;-4.67,3.85,;-6,4.62,;-7.34,3.85,;-7.34,2.31,;-8.67,1.54,;-8.67,,;-7.34,-.77,;-7.34,-2.31,;-6,-3.08,;-4.67,-2.31,;-3.33,-3.08,;-3.33,-4.62,;-4.67,-5.39,;-6,-4.62,;-2,-5.39,;-2,-6.93,;-.67,-7.7,;.67,-6.93,;.67,-5.39,;-.67,-4.62,;-6,,;-6,1.54,;-4.67,2.31,;3.33,3.85,;2,3.08,)| Show InChI InChI=1S/C35H37FN6O4/c36-26-6-1-5-25(21-26)32(23-43)42-15-3-7-29(35(42)45)34(44)37-14-2-4-24-8-13-30-31(20-24)40-33(22-38-30)39-27-9-11-28(12-10-27)41-16-18-46-19-17-41/h1,3,5-8,13,15,20-22,27-28,32,43H,9-12,14,16-19,23H2,(H,37,44)(H,39,40)/t27-,28-,32-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105334 (US8575203, I-101) Show SMILES CN1CCCC(COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(Cc3ccc(F)c(F)c3)c2=O)C1 Show InChI InChI=1S/C32H30F2N4O3/c1-37-15-3-6-24(19-37)21-41-30-12-14-35-29-11-9-22(17-26(29)30)5-2-13-36-31(39)25-7-4-16-38(32(25)40)20-23-8-10-27(33)28(34)18-23/h4,7-12,14,16-18,24H,3,6,13,15,19-21H2,1H3,(H,36,39)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105360 (US8575203, I-125.2) Show SMILES CN(C)CCCOc1ccnc2ccc(cc12)C#CCNC(=O)c1cccn(Cc2cc(F)c(F)c(F)c2)c1=O Show InChI InChI=1S/C30H27F3N4O3/c1-36(2)13-5-15-40-27-10-12-34-26-9-8-20(16-23(26)27)6-3-11-35-29(38)22-7-4-14-37(30(22)39)19-21-17-24(31)28(33)25(32)18-21/h4,7-10,12,14,16-18H,5,11,13,15,19H2,1-2H3,(H,35,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105361 (US8575203, I-125.3) Show SMILES CN(C)CCCCOc1ccnc2ccc(cc12)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C30H29F2N5O3/c1-36(2)14-3-4-15-40-28-11-13-34-27-10-8-21(16-23(27)28)6-5-12-35-29(38)24-18-33-20-37(30(24)39)19-22-7-9-25(31)26(32)17-22/h7-11,13,16-18,20H,3-4,12,14-15,19H2,1-2H3,(H,35,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105255 (US8575203, II-22) Show SMILES CCN1CCC(CC1)Nc1cnc2ccc(cc2n1)C#CCNC(=O)c1cncn(Cc2ccc(F)c(F)c2)c1=O Show InChI InChI=1S/C30H29F2N7O2/c1-2-38-12-9-22(10-13-38)36-28-17-35-26-8-6-20(15-27(26)37-28)4-3-11-34-29(40)23-16-33-19-39(30(23)41)18-21-5-7-24(31)25(32)14-21/h5-8,14-17,19,22H,2,9-13,18H2,1H3,(H,34,40)(H,36,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair
3-phosphoinositide-dependent protein kinase 1 (Homo sapiens (Human))	BDBM105370 (US8575203, I-125.12) Show SMILES CN1CC[C@@H](COc2ccnc3ccc(cc23)C#CCNC(=O)c2cccn(Cc3cc(F)c(F)c(F)c3)c2=O)C1 |r| Show InChI InChI=1S/C31H27F3N4O3/c1-37-13-9-21(17-37)19-41-28-8-11-35-27-7-6-20(14-24(27)28)4-2-10-36-30(39)23-5-3-12-38(31(23)40)18-22-15-25(32)29(34)26(33)16-22/h3,5-8,11-12,14-16,21H,9-10,13,17-19H2,1H3,(H,36,39)/t21-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vit...				US Patent US8575203 (2013) BindingDB Entry DOI: 10.7270/Q2HD7T91
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 258 total )  |  Next  |  Last  >>

Jump to: